Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Aligos Therapeutics, Inc. ALGS

Set alert

Price alert · ALGS

All alert types
4.91 USD +0.31 +6.79%

As of Nov 3, 12:47 PM ET

Bid
4.69 × 2
Ask
4.94 × 2
4.65 Day range 4.95
3.98 52-week range 13.69
YTD
-47.29%
1 year
-34.76%
Open
4.65
Prev close
4.60
Mkt cap
30.68M
Vol
7.25K
Avg vol
70.54K
EPS
-7.41
P/E
0.00
Div yield
0.00%
More statistics
Low
4.65
High
4.95
Forward P/E
-3.30
Beta
2.12
Short ratio
0.50
Inst. own
48.86%
Dividend
0.00
Ex-div date
Earnings
Aug 6, 2024
50-d avg
19.24
200-d avg
16.32
1y target
103.33

1M chart

Chart tools
Interval
1m5m15m30m

Signals (9)
NameDateAgo
SMA: BullishNov 3, 20263 hours ago
MACD: Buy SignalNov 3, 20263 hours ago
MACD: Sell SignalNov 2, 20261 day ago
SMA: BearishOct 30, 20264 days ago
MACD: Buy SignalOct 29, 20265 days ago
SMA: BullishOct 28, 20266 days ago
MACD: Sell SignalOct 16, 20262 weeks ago
SMA: BearishOct 14, 20262 weeks ago
SMA: BullishOct 12, 20263 weeks ago

Financial health

Altman Z-Score

-16.11 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -3.8×
FY 2018: -563×FY 2019: -156×FY 2020: -217×FY 2021: -92.2×FY 2022: -10.6×FY 2023: -4.7×FY 2024: -1.9×FY 2025: -3.8×
FY 2018 5y median -4.7× FY 2025
P/S 42.1×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 2713×FY 2022: 73.1×FY 2023: 26.6×FY 2024: 63.3×FY 2025: 42.1×
FY 2018 5y median 63.3× FY 2025
P/B 1.7×
FY 2018: -572×FY 2019: -125×FY 2020: 107×FY 2021: 64.0×FY 2022: 9.8×FY 2023: 4.5×FY 2024: -8.6×FY 2025: 1.7×
FY 2018 5y median 4.5× FY 2025
P/FCF -1.1×
FY 2018: -918×FY 2019: -164×FY 2020: -310×FY 2021: -101×FY 2022: -12.7×FY 2023: -5.2×FY 2024: -3.1×FY 2025: -1.1×
FY 2018 5y median -5.2× FY 2025
EV/EBITDA -3.4×
FY 2018: -635×FY 2019: -162×FY 2020: -223×FY 2021: -93.7×FY 2022: -10.3×FY 2023: -3.4×FY 2024: -1.7×FY 2025: -3.4×
FY 2018 5y median -3.4× FY 2025
EV/Sales 36.2×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 2674×FY 2022: 68.2×FY 2023: 18.6×FY 2024: 56.0×FY 2025: 36.2×
FY 2018 5y median 56.0× FY 2025
FCF Yield -90.0%
FY 2018: -0.1%FY 2019: -0.6%FY 2020: -0.3%FY 2021: -1.0%FY 2022: -7.9%FY 2023: -19.1%FY 2024: -32.4%FY 2025: -90.0%
FY 2018 5y median -19.1% FY 2025

Profitability

Gross Margin 57.5%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 57.5%
FY 2018 5y median 100.0% FY 2025
Operating Margin -4024.9%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -2943.8%FY 2022: -701.7%FY 2023: -567.5%FY 2024: -2259.9%FY 2025: -4024.9%
FY 2018 5y median -2259.9% FY 2025
Net Margin -1106.7%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -2944.1%FY 2022: -690.6%FY 2023: -564.6%FY 2024: -3326.0%FY 2025: -1106.7%
FY 2018 5y median -1106.7% FY 2025
ROE -45.2%
FY 2018: 101.3%FY 2019: 80.5%FY 2020: -49.3%FY 2021: -69.5%FY 2022: -92.4%FY 2023: -95.2%FY 2024: 452.9%FY 2025: -45.2%
FY 2018 5y median -69.5% FY 2025
ROIC -123.9%
FY 2018: -13.5%FY 2019: -40.0%FY 2020: -41.2%FY 2021: -64.4%FY 2022: -83.6%FY 2023: -67.3%FY 2024: -172.1%FY 2025: -123.9%
FY 2018 5y median -83.6% FY 2025
ROA -27.3%
FY 2018: -12.9%FY 2019: -35.7%FY 2020: -40.9%FY 2021: -54.5%FY 2022: -65.5%FY 2023: -57.9%FY 2024: -187.2%FY 2025: -27.3%
FY 2018 5y median -57.9% FY 2025

Growth (YoY)

Revenue -44.6%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 219.0%FY 2023: 11.7%FY 2024: -74.6%FY 2025: -44.6%
FY 2018 FY 2025
Operating Income 1.3%
FY 2018: 0.0%FY 2019: -295.6%FY 2020: -81.0%FY 2021: -31.2%FY 2022: 24.0%FY 2023: 9.7%FY 2024: -1.2%FY 2025: 1.3%
FY 2018 FY 2025
EPS (diluted) 88.3%
FY 2018: 0.0%FY 2019: -260.6%FY 2020: -33.6%FY 2021: -1.3%FY 2022: 30.1%FY 2023: -56.4%FY 2024: -494.9%FY 2025: 88.3%
FY 2018 FY 2025
Free Cash Flow -2.6%
FY 2018: 0.0%FY 2019: -478.6%FY 2020: -54.0%FY 2021: -52.7%FY 2022: 31.1%FY 2023: 1.6%FY 2024: -2.4%FY 2025: -2.6%
FY 2018 FY 2025

Financial Health

Current Ratio 3.9×
FY 2018: 12.3×FY 2019: 8.7×FY 2020: 8.3×FY 2021: 5.2×FY 2022: 4.0×FY 2023: 5.9×FY 2024: 2.9×FY 2025: 3.9×
FY 2018 5y median 4.0× FY 2025
Quick Ratio 3.9×
FY 2018: 12.3×FY 2019: 8.7×FY 2020: 8.3×FY 2021: 5.2×FY 2022: 4.0×FY 2023: 5.9×FY 2024: 2.9×FY 2025: 3.9×
FY 2018 5y median 4.0× FY 2025
Debt / Equity 0.1×
FY 2018: -1.0×FY 2019: -0.2×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: -0.3×FY 2025: 0.1×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 0.6×
FY 2018: 0.8×FY 2019: 1.1×FY 2020: 2.0×FY 2021: 1.4×FY 2022: 0.7×FY 2023: 1.5×FY 2024: 0.2×FY 2025: 0.6×
FY 2018 5y median 0.7× FY 2025
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: -9.3×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31